Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

Shares of Bicycle Therapeutics PLC Sponsored ADR (BCYC) have gained 8.1% over the past four weeks to close the last trading session at $24.58, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$43.56 indicates a potential upside of 77.2%.The average comprises nine short-term price targets ranging from a low of $30 to a high of$60, with a standard deviation of $11.61. While the lo ...